Institutions / B Group, Inc.
B Group, Inc.
CIK 2043476 · Institution · as of Dec 31, 2025
Portfolio value
$134.95M
Positions
15
As of
Dec 31, 2025
Top holdings
Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| ADMA Biologics Inc | $44.83M | 33.2% |
| Cellectis S a | $15.88M | 11.8% |
| Palisade Bio, Inc. | $10.57M | 7.8% |
| Taysha Gene Therapies, Inc.TSHA | $9.90M | 7.3% |
| Praxis Precision Medicines, Inc. | $9.80M | 7.3% |
| Sight Sciences, Inc.SGHT | $7.30M | 5.4% |
| Zai Lab Limited | $7.06M | 5.2% |
| Structure Therapeutics Inc.GPCR | $6.26M | 4.6% |
| Assembly Biosciences, Inc.ASMB | $5.98M | 4.4% |
| Iovance Biotherapeutics, Inc. | $4.09M | 3.0% |
| Spyre Therapeutics, Inc. | $3.28M | 2.4% |
| Aura Biosciences, Inc.AURA | $3.12M | 2.3% |
| Ultragenyx Pharmaceutical Inc. | $3.10M | 2.3% |
| Oruka Therapeutics, Inc. | $2.27M | 1.7% |
| Apogee Therapeutics, Inc. | $1.51M | 1.1% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.